158 related articles for article (PubMed ID: 15297772)
21. Infliximab in ulcerative colitis.
Böcker U
Scand J Gastroenterol; 2006 Sep; 41(9):997-1000. PubMed ID: 16938710
[No Abstract] [Full Text] [Related]
22. Safety of infliximab and other biologic agents in the inflammatory bowel diseases.
Reddy JG; Loftus EV
Gastroenterol Clin North Am; 2006 Dec; 35(4):837-55. PubMed ID: 17129816
[TBL] [Abstract][Full Text] [Related]
23. Safety of infliximab in 10 years of clinical practice.
O'Donnell S; Murphy S; Anwar MM; O'Sullivan M; Breslin N; O'Connor HJ; Ryan BM; O'Morain CA
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):603-6. PubMed ID: 21602689
[TBL] [Abstract][Full Text] [Related]
24. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
Arijs I; Li K; Toedter G; Quintens R; Van Lommel L; Van Steen K; Leemans P; De Hertogh G; Lemaire K; Ferrante M; Schnitzler F; Thorrez L; Ma K; Song XY; Marano C; Van Assche G; Vermeire S; Geboes K; Schuit F; Baribaud F; Rutgeerts P
Gut; 2009 Dec; 58(12):1612-9. PubMed ID: 19700435
[TBL] [Abstract][Full Text] [Related]
25. The effect of controlling inflammatory activity in the colon on the response to infliximab of autoimmune haemolytic anaemia associated with ulcerative colitis.
Leo-Carnerero E; Araujo-Míguez A; Trigo-Salado C; De-la-Cruz-Ramírez MD; Herrera-Justiniano JM; Márquez-Galán JL
Rev Esp Enferm Dig; 2014 Apr; 106(4):295-6. PubMed ID: 25075665
[No Abstract] [Full Text] [Related]
26. Management of acute severe ulcerative colitis.
Doherty GA; Cheifetz AS
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
[TBL] [Abstract][Full Text] [Related]
27. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Mocciaro F; Orlando A; Scimeca D; Cottone M
Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
[TBL] [Abstract][Full Text] [Related]
28. Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis.
Veerappan SG; O'Morain CA
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):830-2. PubMed ID: 19398919
[TBL] [Abstract][Full Text] [Related]
29. Infliximab for refractory ulcerative colitis.
Chey WY; Hussain A; Ryan C; Potter GD; Shah A
Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
[TBL] [Abstract][Full Text] [Related]
30. Comment on the comment of Dr. Daniel Present.
Chey WY; Shah AN
Am J Gastroenterol; 2002 Apr; 97(4):1066. PubMed ID: 12003395
[No Abstract] [Full Text] [Related]
31. Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice.
Tursi A; Elisei W; Brandimarte G; Giorgetti G; Penna A; Castrignano V
Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):47-55. PubMed ID: 20184089
[TBL] [Abstract][Full Text] [Related]
32. Pustular psoriasis induced by infliximab.
Thurber M; Feasel A; Stroehlein J; Hymes SR
J Drugs Dermatol; 2004; 3(4):439-40. PubMed ID: 15303790
[TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
[No Abstract] [Full Text] [Related]
34. Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?
Gearry RB; Irving PM
J Gastroenterol Hepatol; 2009 Jul; 24(7):1160-2. PubMed ID: 19682189
[No Abstract] [Full Text] [Related]
35. Anti-tumor necrosis factor therapy for ulcerative colitis.
Kountouras J; Zavos C; Chatzopoulos D
Gastroenterology; 2005 Sep; 129(3):1138-9. PubMed ID: 16143158
[No Abstract] [Full Text] [Related]
36. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
37. Infliximab or cyclosporine for severe ulcerative colitis.
Järnerot G
Gastroenterology; 2006 Jan; 130(1):286; author reply 287. PubMed ID: 16401502
[No Abstract] [Full Text] [Related]
38. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.
Baudet A; Colombel JF; Cortot A; Dupas JL; Brazier F; Savoye G; Lerebours E; Justum AM; Reimund JM
Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218
[TBL] [Abstract][Full Text] [Related]
39. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
40. Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective.
Koltun WA
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):325-7. PubMed ID: 19673618
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
